Your Trusted Partner in High-Quality Healthcare Solutions

Overview of Emphasis Pharma Private Limited

Emphasis Pharma Private Limited is an Indian pharmaceutical company based in Madhya Pradesh. It is primarily involved in the manufacturing, marketing, and supply of various pharmaceutical and chemical products.

Corporate Profile

• Date of Incorporation: January 1, 2014
• Company Status: Active (Unlisted Private Company)
• Registered Office: H No. 01, Street No 06, Ibrahimganj, Bhopal, Madhya Pradesh, India
• Registrar of Companies: RoC - Gwalior
• CIN: U24233MP2014PTC032055
• Key Directors: Abid Khan & Vinay Maithil

Business Operations & Financials

Industry Classification: Production of pharmaceuticals, medicinal chemicals, and botanical products (including Ayurvedic and Unani formulations).
Financial Performance: FY25 estimated annual revenue/turnover of approximately ₹3.21 Crore.

Key Products Portfolio

• Sufinac P / Sufinac SP – Analgesic and anti‑inflammatory tablets (Aceclofenac & Paracetamol).
• Lemosine Cold / Lemosine – Cold, cough and allergy formulations.
• Femstrual / Femstrual M – Menstrual pain relief.
• Protolet D / Protolet – Antacid and gastrointestinal medicines.
• Cortihope – Corticosteroid medications for inflammatory conditions.

Emphasis Pharma Private Limited

Emphasis Pharma Private Limited is an active pharmaceutical company incorporated in 2014 under the Ministry of Corporate Affairs, Government of India, with its registered headquarters in Bhopal, Madhya Pradesh. The firm is led by directors Abid Khan and Vinay Maithil.